Literature DB >> 17535551

Histologic and transcriptional assessment of a mild SMA model.

Sylvia Balabanian1, Nathalie H Gendron, Alex E MacKenzie.   

Abstract

Spinal muscular atrophy (SMA) is caused by survival of motor neuron (SMN) deficiency, leading to specific motor neuron attrition. The time course and molecular pathophysiologic etiology of motor neuron loss observed in SMA remains obscure. Mice heterozygous for Smn show up to 50% motor neuron attrition by 6 months of age and are used as a model for mild SMA in humans. To determine both the rate of cellular loss and the molecular events underlying motor neuron degeneration in SMA, motor neuron counts and mRNA quantification were performed in spinal cords of Smn(+/-) mice and wild-type littermates. Surprisingly, despite the chronic, subclinical nature of motor neuron loss, we find that the bulk of the loss occurs by 5 weeks of age. RNA isolated from the spinal cords of 5 week-old Smn(+/-) mice subjected to microarray analysis reveal alterations in genes involved in RNA metabolism, apoptosis and transcriptional regulation including a general perturbation of transcripts coding for calcium binding proteins. A subset of these changes in expression was further characterized by semi-quantitative RT-PCR and Western blot analysis at various time points. Taken together, these results indicate that spinal cord cells present the first signs of the apoptotic process consistent with a response to the stress of Smn depletion. A picture of comparatively rapid neuronal attrition in spite of the very mild nature of SMA is obtained. Furthermore, changes occur, which may be reactive to and not causative of the cellular loss, involving central cellular functions as well as calcium modulating proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535551     DOI: 10.1179/016164107X159243

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  7 in total

1.  Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.

Authors:  Esther Udina; Charles T Putman; Luke R Harris; Neil Tyreman; Victoria E Cook; Tessa Gordon
Journal:  J Physiol       Date:  2017-01-25       Impact factor: 5.182

2.  Behavioral and electrophysiological outcomes of tissue-specific Smn knockdown in Drosophila melanogaster.

Authors:  Christina Timmerman; Subhabrata Sanyal
Journal:  Brain Res       Date:  2012-10-26       Impact factor: 3.252

Review 3.  The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

Authors:  James N Sleigh; Thomas H Gillingwater; Kevin Talbot
Journal:  Dis Model Mech       Date:  2011-07       Impact factor: 5.758

4.  A novel role for CARM1 in promoting nonsense-mediated mRNA decay: potential implications for spinal muscular atrophy.

Authors:  Gabriel Sanchez; Emma Bondy-Chorney; Janik Laframboise; Geneviève Paris; Andréanne Didillon; Bernard J Jasmin; Jocelyn Côté
Journal:  Nucleic Acids Res       Date:  2015-12-09       Impact factor: 16.971

5.  Splicing changes in SMA mouse motoneurons and SMN-depleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins.

Authors:  Qing Huo; Melis Kayikci; Philipp Odermatt; Kathrin Meyer; Olivia Michels; Smita Saxena; Jernej Ule; Daniel Schümperli
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  Single-cell RNA sequencing reveals dysregulation of spinal cord cell types in a severe spinal muscular atrophy mouse model.

Authors:  Junjie Sun; Jiaying Qiu; Qiongxia Yang; Qianqian Ju; Ruobing Qu; Xu Wang; Liucheng Wu; Lingyan Xing
Journal:  PLoS Genet       Date:  2022-09-08       Impact factor: 6.020

7.  SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.

Authors:  Zhenxi Zhang; Francesco Lotti; Kimberly Dittmar; Ihab Younis; Lili Wan; Mumtaz Kasim; Gideon Dreyfuss
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.